Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
STATE OF MINNESOTA, BY ITS ATTORNEY GENERAL KEITH ELLISON v. SANOFI-AVENTIS U.S. LLC et al
Case Number:
3:18-cv-14999
Court:
Nature of Suit:
Racketeer/Corrupt Organization
Judge:
Firms
Companies
Sectors & Industries:
-
March 12, 2021
Minn. AG's Insulin Suit Against Sanofi, Eli Lilly Gutted
A New Jersey federal judge gutted a lawsuit Friday from Minnesota's attorney general accusing Sanofi-Aventis US LLC, Novo Nordisk Inc. and Eli Lilly & Co. of jacking up insulin prices, tossing 13 claims out of 16.
-
August 26, 2020
Minn. Pushes Back On Drug Cos.' Bid To Kill Insulin RICO Suit
Minnesota's attorney general has pushed back against three pharmaceutical giants trying to escape a suit accusing them of jacking up insulin prices, saying a New Jersey federal court wields the power to break up alleged schemes harming the public.
-
April 02, 2020
Minn. AG's Insulin Pricing Suit Survives, Minus RICO Claims
Sanofi-Aventis, Novo Nordisk and Eli Lilly can't toss all claims in the Minnesota attorney general's antitrust lawsuit against them over soaring insulin pricing, a New Jersey federal judge said.
-
September 26, 2019
Minn. AG Defends Insulin Suit Against Sanofi, Novo, Lilly
The Minnesota attorney general's office urged a New Jersey federal judge Thursday not to toss an insulin pricing lawsuit against Sanofi-Aventis U.S. LLC, Novo Nordisk Inc. and Eli Lilly and Co., arguing that the attorney general is allowed to pursue damages on behalf of state residents.
-
August 13, 2019
Sanofi, Novo, Lilly Look To Ditch Minn. AG's Insulin Suit
Sanofi-Aventis U.S. LLC, Novo Nordisk Inc. and Eli Lilly and Co. urged a New Jersey federal judge Monday to toss the Minnesota attorney general's insulin pricing lawsuit against them, arguing that the racketeering allegations of deceptive prices are undone by Minnesota law and the state's own practices.